Purpose Younger women diagnosed with breast cancer have poorer prognoses and higher
mortality compared to older women. Young black women have higher incidence rates of …

Using nationwide data, this study estimated and compared annual health care expenditures
per person between noncancer and cancer patients, and among patients with the 4 most …

Background This study projected the number of metastatic breast cancer (mBC) cases and
costs (medical and productivity) attributable to mBC through 2030 among 3 age groups …

In the past four decades, substantial progress has been made in breast cancer survival in
part because of advances in early detection and treatment following diagnosis. 1, 2 Further …

Introduction No study has quantified productivity losses associated with breast cancer in
younger women aged 18–44 years. This study estimated productivity costs, including work …

Purpose We estimated average medical costs due to metastatic breast cancer (mBC) among
younger (aged 18–44), midlife (aged 45–64), and older women (aged 65 and older) by …

Backgrounds Breast cancer is the most prevalent cancer among women. Breast cancer
imposes a considerable economic burden on the health system. This study aimed to …

Objective: To estimate breast cancer treatment and health care services costs by stage at
diagnosis among Missouri's Medicaid beneficiaries and assess the SMHW program impact …

Purpose Younger women (under age 45 years) diagnosed with breast cancer often face
more aggressive tumors, higher treatment intensity, lower survival rates, and greater …

Introduction Triple-negative breast cancer (TNBC) is associated with a high recurrence risk.
However, the magnitude of direct and indirect costs associated with recurrence is lacking in …